Literature DB >> 20089645

Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques.

Myrna C Bonaldo1, Mauricio A Martins, Richard Rudersdorf, Philip A Mudd, Jonah B Sacha, Shari M Piaskowski, Patrícia C Costa Neves, Marlon G Veloso de Santana, Lara Vojnov, Saverio Capuano, Eva G Rakasz, Nancy A Wilson, John Fulkerson, Jerald C Sadoff, David I Watkins, Ricardo Galler.   

Abstract

Here we describe a novel vaccine vector for expressing human immunodeficiency virus (HIV) antigens. We show that recombinant attenuated yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 Gag sequences can be used as a vector to generate SIV-specific CD8(+) T-cell responses in the rhesus macaque. Priming with recombinant BCG expressing SIV antigens increased the frequency of these SIV-specific CD8(+) T-cell responses after recombinant YF17D boosting. These recombinant YF17D-induced SIV-specific CD8(+) T cells secreted several cytokines, were largely effector memory T cells, and suppressed viral replication in CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089645      PMCID: PMC2838090          DOI: 10.1128/JVI.02255-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

Authors:  Thomas P Monath; Farshad Guirakhoo; Richard Nichols; Sutee Yoksan; Robert Schrader; Chris Murphy; Paul Blum; Stephen Woodward; Karen McCarthy; Danell Mathis; Casey Johnson; Philip Bedford
Journal:  J Infect Dis       Date:  2003-10-03       Impact factor: 5.226

2.  HIV vaccine design and the neutralizing antibody problem.

Authors:  Dennis R Burton; Ronald C Desrosiers; Robert W Doms; Wayne C Koff; Peter D Kwong; John P Moore; Gary J Nabel; Joseph Sodroski; Ian A Wilson; Richard T Wyatt
Journal:  Nat Immunol       Date:  2004-03       Impact factor: 25.606

3.  Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques.

Authors:  Philip R Johnson; Bruce C Schnepp; Mary J Connell; Daniela Rohne; Suzanne Robinson; Georgia R Krivulka; Carol I Lord; Rebekah Zinn; David C Montefiori; Norman L Letvin; K Reed Clark
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

Authors:  J Benson; C Chougnet; M Robert-Guroff; D Montefiori; P Markham; G Shearer; R C Gallo; M Cranage; E Paoletti; K Limbach; D Venzon; J Tartaglia; G Franchini
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660.

Authors:  Robert E Johnston; Philip R Johnson; Mary J Connell; David C Montefiori; Ande West; Martha L Collier; Chad Cecil; Ronald Swanstrom; Jeffrey A Frelinger; Nancy L Davis
Journal:  Vaccine       Date:  2005-10-10       Impact factor: 3.641

6.  A computational resource for the prediction of peptide binding to Indian rhesus macaque MHC class I molecules.

Authors:  B Peters; H-H Bui; J Sidney; Z Weng; J T Loffredo; D I Watkins; B R Mothé; A Sette
Journal:  Vaccine       Date:  2005-08-18       Impact factor: 3.641

Review 7.  Protective immunity elicited by rBCG vaccines.

Authors:  C K Stover; G P Bansal; S Langerman; M S Hanson
Journal:  Dev Biol Stand       Date:  1994

8.  Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.

Authors:  T Hanke; R V Samuel; T J Blanchard; V C Neumann; T M Allen; J E Boyson; S A Sharpe; N Cook; G L Smith; D I Watkins; M P Cranage; A J McMichael
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

9.  Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection.

Authors:  Todd M Allen; Peicheng Jing; Briana Calore; Helen Horton; David H O'Connor; Tomas Hanke; Marian Piekarczyk; Richard Ruddersdorf; Bianca R Mothé; Carol Emerson; Nancy Wilson; Jeffrey D Lifson; Igor M Belyakov; Jay A Berzofsky; Chenxi Wang; David B Allison; David C Montefiori; Ronald C Desrosiers; Steven Wolinsky; Kevin J Kunstman; John D Altman; Alessandro Sette; Andrew J McMichael; David I Watkins
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model.

Authors:  Deng Tao; Giovanna Barba-Spaeth; Urvashi Rai; Victor Nussenzweig; Charles M Rice; Ruth S Nussenzweig
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

View more
  30 in total

1.  Live attenuated rubella viral vectors stably express HIV and SIV vaccine antigens while reaching high titers.

Authors:  Konstantin Virnik; Yisheng Ni; Ira Berkower
Journal:  Vaccine       Date:  2012-07-06       Impact factor: 3.641

2.  Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques.

Authors:  Katherine M Mladinich; Shari M Piaskowski; Richard Rudersdorf; Christopher M Eernisse; Kim L Weisgrau; Mauricio A Martins; Jessica R Furlott; Charalambos D Partidos; Joseph N Brewoo; Jorge E Osorio; Nancy A Wilson; Eva G Rakasz; David I Watkins
Journal:  Immunogenetics       Date:  2011-09-01       Impact factor: 2.846

3.  Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection.

Authors:  Mauricio A Martins; Damien C Tully; Michael A Cruz; Karen A Power; Marlon G Veloso de Santana; David J Bean; Colin B Ogilvie; Rujuta Gadgil; Noemia S Lima; Diogo M Magnani; Keisuke Ejima; David B Allison; Michael Piatak; John D Altman; Christopher L Parks; Eva G Rakasz; Saverio Capuano; Ricardo Galler; Myrna C Bonaldo; Jeffrey D Lifson; Todd M Allen; David I Watkins
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

Review 4.  The yellow fever 17D virus as a platform for new live attenuated vaccines.

Authors:  Myrna C Bonaldo; Patrícia C Sequeira; Ricardo Galler
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

5.  Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.

Authors:  Enoch Muyanja; Aloysius Ssemaganda; Pearline Ngauv; Rafael Cubas; Helene Perrin; Divya Srinivasan; Glenda Canderan; Benton Lawson; Jakub Kopycinski; Amanda S Graham; Dawne K Rowe; Michaela J Smith; Sharon Isern; Scott Michael; Guido Silvestri; Thomas H Vanderford; Erika Castro; Giuseppe Pantaleo; Joel Singer; Jill Gillmour; Noah Kiwanuka; Annet Nanvubya; Claudia Schmidt; Josephine Birungi; Josephine Cox; Elias K Haddad; Pontiano Kaleebu; Patricia Fast; Rafick-Pierre Sekaly; Lydie Trautmann; Denis Gaucher
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

6.  Improved genetic stability of recombinant yellow fever 17D virus expressing a lentiviral Gag gene fragment.

Authors:  Marlon G Veloso de Santana; Patrícia C C Neves; Juliana Ribeiro dos Santos; Noemia S Lima; Alexandre A C dos Santos; David I Watkins; Ricardo Galler; Myrna C Bonaldo
Journal:  Virology       Date:  2014-02-08       Impact factor: 3.616

7.  Vaccine-induced CD8+ T cells control AIDS virus replication.

Authors:  Philip A Mudd; Mauricio A Martins; Adam J Ericsen; Damien C Tully; Karen A Power; Alex T Bean; Shari M Piaskowski; Lijie Duan; Aaron Seese; Adrianne D Gladden; Kim L Weisgrau; Jessica R Furlott; Young-il Kim; Marlon G Veloso de Santana; Eva Rakasz; Saverio Capuano; Nancy A Wilson; Myrna C Bonaldo; Ricardo Galler; David B Allison; Michael Piatak; Ashley T Haase; Jeffrey D Lifson; Todd M Allen; David I Watkins
Journal:  Nature       Date:  2012-09-30       Impact factor: 49.962

8.  Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120.

Authors:  Jae-Sung Yu; Hua-Xin Liao; Jamie Pritchett; Cindy Bowman; Callie Vivian; Robert Parks; Shi-Mao Xia; Melissa Cooper; Wilton B Williams; Mattia Bonsignori; Steven G Reed; Meng Chen; Nathan Vandergrift; Charles M Rice; Barton F Haynes
Journal:  J Virol Methods       Date:  2017-08-31       Impact factor: 2.014

9.  Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications.

Authors:  Helen L Wu; Whitney C Weber; Christine Shriver-Munsch; Tonya Swanson; Mina Northrup; Heidi Price; Kimberly Armantrout; Mitchell Robertson-LeVay; Jason S Reed; Katherine B Bateman; Eisa Mahyari; Archana Thomas; Stephanie L Junell; Theodore R Hobbs; Lauren D Martin; Rhonda MacAllister; Benjamin N Bimber; Mark K Slifka; Alfred W Legasse; Cassandra Moats; Michael K Axthelm; Jeremy Smedley; Anne D Lewis; Lois Colgin; Gabrielle Meyers; Richard T Maziarz; Benjamin J Burwitz; Jeffrey J Stanton; Jonah B Sacha
Journal:  Xenotransplantation       Date:  2020-01-13       Impact factor: 3.907

10.  Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques.

Authors:  Jeanette C Reece; Sheilajen Alcantara; Shayarana Gooneratne; Sinthujan Jegaskanda; Thakshila Amaresena; Caroline S Fernandez; Karen Laurie; Aeron Hurt; Shelby L O'Connor; Max Harris; Janka Petravic; Alexey Martyushev; Andrew Grimm; Miles P Davenport; John Stambas; Robert De Rose; Stephen J Kent
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.